New blood pressure drug QLS1410 enters first human tests
NCT ID NCT07152444
First seen Nov 01, 2025 · Last updated May 17, 2026 · Updated 31 times
Summary
This early-stage trial tests the safety and tolerability of a new drug called QLS1410 in 78 healthy Chinese adults and people with mild high blood pressure. Researchers will give single and multiple doses to see how the body processes the drug and how food affects it. The goal is to gather initial safety data, not to treat the condition yet.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCONTROLLED HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Third Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.